Search Results - "Henao Restrepo, Ana Maria"

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats by Longini, Ira M, Yang, Yang, Fleming, Thomas R, Muñoz-Fontela, César, Wang, Rui, Ellenberg, Susan S, Qian, George, Halloran, M Elizabeth, Nason, Martha, Gruttola, Victor De, Mulangu, Sabue, Huang, Yunda, Donnelly, Christl A, Henao Restrepo, Ana-Maria

“…Background: The threat of a possible Marburg virus disease outbreak in Central and Western Africa is growing. While no Marburg virus vaccines are currently…”
Get full text

COVID-19 vaccine trials: The use of active controls and non-inferiority studies by Fleming, Thomas R, Krause, Philip R, Nason, Martha, Longini, Ira M, Henao-Restrepo, Ana-Maria M

“…Background: Recently emerging results from a few placebo-controlled randomized trials of COVID-19 vaccines revealed estimates of 62%–95% relative reductions in…”
Get full text

Considerations in boosting COVID-19 vaccine immune responses by Krause, Philip R, Fleming, Thomas R, Peto, Richard, Longini, Ira M, Figueroa, J Peter, Sterne, Jonathan A C, Cravioto, Alejandro, Rees, Helen, Higgins, Julian P T, Boutron, Isabelle, Pan, Hongchao, Gruber, Marion F, Arora, Narendra, Kazi, Fatema, Gaspar, Rogerio, Swaminathan, Soumya, Ryan, Michael J, Henao-Restrepo, Ana-Maria

“…A new wave of COVID-19 cases caused by the highly transmissible delta variant is exacerbating the worldwide public health crisis, and has led to consideration…”
Get full text

Ebola Vaccine — An Urgent International Priority by Kanapathipillai, Rupa, Henao Restrepo, Ana Maria, Fast, Patricia, Wood, David, Dye, Christopher, Kieny, Marie-Paule, Moorthy, Vasee

“…With the Ebola epidemic in West Africa continuing to grow, the World Health Organization convened an urgent meeting on September 29 and 30 to assess the…”
Get full text

COVID-19 vaccine trials: The potential for “hybrid” analyses by Fleming, Thomas R, Nason, Martha, Krause, Philip R, Longini, Ira M, Henao-Restrepo, Ana-Maria

“…Background: Although several COVID-19 vaccines have been found to be effective in rigorous evaluation and have emerging availability in parts of the world,…”
Get full text

Data sharing for novel coronavirus (COVID-19) by Moorthy, Vasee, Henao Restrepo, Ana Maria, Preziosi, Marie-Pierre, Swaminathan, Soumya

Get full text

Electronic Data Management for Vaccine Trials in Low Resource Settings: Upgrades, Scalability, and Impact of ODK by Marks, Michael, Lal, Sham, Brindle, Hannah, Gsell, Pierre-Stéphane, MacGregor, Matthew, Stott, Callum, van de Rijdt, Martijn, Almazor, Guillermo Gutiérrez, Golia, Suman, Watson, Conall, Diallo, Abdourahamane, Toure, Alhassane, Houlihan, Catherine, Keating, Patrick, Martin, Hélène, Restrepo, Ana-Maria Henao, Anokwa, Yaw, Roberts, Chrissy H

“…ODK provides software and standards that are popular solutions for off-grid electronic data collection and has substantial code overlap and interoperability…”
Get full text

SARS-CoV-2 Variants and Vaccines by Krause, Philip R, Fleming, Thomas R, Longini, Ira M, Peto, Richard, Briand, Sylvie, Heymann, David L, Beral, Valerie, Snape, Matthew D, Rees, Helen, Ropero, Alba-Maria, Balicer, Ran D, Cramer, Jakob P, Muñoz-Fontela, César, Gruber, Marion, Gaspar, Rogerio, Singh, Jerome A, Subbarao, Kanta, Van Kerkhove, Maria D, Swaminathan, Soumya, Ryan, Michael J, Henao-Restrepo, Ana-Maria

“…Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019…”
Get full text

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial by Henao-Restrepo, Ana Maria, MD, Longini, Ira M, Prof, Egger, Matthias, Prof, Dean, Natalie E, PhD, Edmunds, W John, Prof, Camacho, Anton, PhD, Carroll, Miles W, PhD, Doumbia, Moussa, MD, Draguez, Bertrand, MD, Duraffour, Sophie, PhD, Enwere, Godwin, FWACP, Grais, Rebecca, PhD, Gunther, Stephan, MD, Hossmann, Stefanie, MSc, Kondé, Mandy Kader, Prof, Kone, Souleymane, MSc, Kuisma, Eeva, PhD, Levine, Myron M, Prof, Mandal, Sema, MD, Norheim, Gunnstein, PhD, Riveros, Ximena, BSc, Soumah, Aboubacar, MD, Trelle, Sven, MD, Vicari, Andrea S, PhD, Watson, Conall H, MFPH, Kéïta, Sakoba, MD, Kieny, Marie Paule, Dr, Røttingen, John-Arne, Prof

“…Summary Background A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus…”
Get full text

Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis by D'Addario, Maddalena, Redmond, Shelagh, Scott, Pippa, Egli-Gany, Dianne, Riveros-Balta, A. Ximena, Henao Restrepo, Ana Maria, Low, Nicola

“…Highlights • Simple schedules for human papillomavirus (HPV) vaccines could improve vaccine effectiveness. • A two-dose HPV vaccine schedule in adolescent…”
Get full text

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae : Updated recommendations from the World Health Organization Pneumococcal Carriage Working Group by Satzke, Catherine, Turner, Paul, Virolainen-Julkunen, Anni, Adrian, Peter V, Antonio, Martin, Hare, Kim M, Henao-Restrepo, Ana Maria, Leach, Amanda J, Klugman, Keith P, Porter, Barbara D, Sá-Leão, Raquel, Scott, J. Anthony, Nohynek, Hanna, O’Brien, Katherine L

“…Highlights • We present updated recommendations from a World Health Organization working group. • These are a core set of standard methods for pneumococcal…”
Get full text

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply by Krause, Philip R, Rees, Helen, Figueroa, J Peter, Swaminathan, Soumya, Restrepo, Ana Maria Henao

Get full text

Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report by Davis, Chris, Tipton, Tom, Sabir, Suleman, Aitken, Celia, Bennett, Susan, Becker, Stephan, Evans, Tom, Fehling, Sarah Katharina, Gunson, Rory, Hall, Yper, Jackson, Celia, Johanssen, Ingolfur, Kieny, Marie Paule, Mcmenamin, Jim, Spence, Elizabeth, Strecker, Thomas, Sykes, Catie, Templeton, Kate, Thorburn, Fiona, Peters, Erica, Henao Restrepo, Ana Maria, White, Beth, Zambon, Maria, Carroll, Miles W, Thomson, Emma C

“…Abstract Background In October 2015, 65 people came into direct contact with a healthcare worker presenting with a late reactivation of Ebola virus disease…”
Get full text

A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles by Low, Nicola, Bavdekar, Ashish, Jeyaseelan, Lakshmanan, Hirve, Siddhivinayak, Ramanathan, Kavitha, Andrews, Nicholas J, Shaikh, Naseem, Jadi, Ramesh S, Rajagopal, Arunachalam, Brown, Kevin E, Brown, David, Fink, James B, John, Oommen, Scott, Pippa, Riveros-Balta, A. Ximena, Greco, Michel, Dhere, Rajeev, Kulkarni, Prasad S, Henao Restrepo, Ana Maria

“…A more convenient delivery system may facilitate increased global use of measles vaccine. In this randomized, controlled trial involving more than 2000…”
Get full text

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013–2016 West Africa Ebola outbreak in Guinea by Boum, Yap, Juan-Giner, Aitana, Hitchings, Matt, Soumah, Aboubacar, Strecker, Thomas, Sadjo, Mariama, Cuthbertson, Hannah, Hayes, Peter, Tchaton, Marie, Jemmy, Jean-Paul, Clarck, Carolyn, King, Deborah, Faga, Elisabetta Maria, Becker, Stephan, Halis, Bassam, Gunnstein, Norheim, Carroll, Miles, Røttingen, John-Arne, Kondé, Mandy Kader, Doumbia, Moise, Henao-Restrepo, Ana-Maria, Kieny, Marie-Paule, Cisse, Mohamed, Draguez, Bertrand, Grais, Rebecca F.

“…•We found rVSVΔG-ZEBOV-GP to be immunogenic at 28- and 180-days post vaccination.•At 28 days post-vaccination, seroresponse rate was higher in the high-risk…”
Get full text

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches) by Watson, Conall H, Gsell, Pierre-Stéphane, Hall, Yper, Camacho, Anton, Riveros, Ximena, Enwere, Godwin, Vicari, Andrea, Nadlaou, Séverine Danmadji, Toure, Alhassane, Sani, Ismaila M, Diallo, Abdourahamane, Kolie, Cece, Duraffour, Sophie, Ifono, Kékoura, Maomou, Andre, Dore, Kassie, Djidonou, Honora A, Bagayoko, Aminata, Damey, Philos P, Camara, Mabetty Nancy, Diallo, Fatoumata Battouly, Oumar, Fofana Thierno, Toure, Kalidou, Diaby, Mohamed Lamine, Sylla, Lansana, Conde, Doussou, Kaba, Ibrahima Lansana, Tipton, Tom, Eggo, Rosalind M, Marks, Michael, Roberts, Chrissy H, Strecker, Thomas, Günther, Stephan, Keita, Sakoba, Edmunds, W. John, Carroll, Miles W, Henao-Restrepo, Ana Maria

“…Abstract Background Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in…”
Get full text

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential by Krause, Philip R, Fleming, Thomas R, Ellenberg, Susan S, Henao-Restrepo, Ana Maria, Krause, PR, Fleming, T, Alejandria, MM, Bhargava, B, Ellenberg, S, Garcia, PJ, Halloran, E, Henao-Restrepo, AM, Longini, I, Miranda Montoya, MC, Roses, M, Sommerfelt, H

“…[...]access to information on the timing of events—ie, the event rate by time after randomisation—in the pooled data could be informative about vaccine…”
Get full text

Experience in Global Measles Control, 1990–2001 by Henao‐Restrepo, Ana‐Maria , Strebel, Peter , John Hoekstra, Edward , Birmingham, Maureen , Bilous, Julian 

“…Worldwide during the 1980s remarkable progress was made in controlling measles through increasing routine measles vaccination to nearly 80%. In 2000, an…”
Get full text

Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis by Low, Nicola, Kraemer, Sibylle, Schneider, Martin, Restrepo, Ana Maria Henao

“…Summary Aerosols are the most promising non-injectable method of measles vaccination studied so far and their efficacy is thought to be comparable to injected…”
Get full text

Comparing pneumococcal conjugate vaccine schedules in infancy by Low, Nicola, Scott, Pippa, Henao Restrepo, Ana Maria

“…Dear Sir, We would like to advise caution about the statistical analyses presented by Rückinger and colleagues, who compare immunological outcomes of…”
Get full text